Scotland · NHS Scotland MSAN
Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-
MSAN(2026)7 · Level 2 · issued 17 Feb 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| solution for injection pre-filled syringes remain available and can support increased demand. | Available | — |
| 4. Ipsen’s lanreotide (Somatuline Autogel®) pre-filled syringes are available via an Ipsen | Available | — |
| accessible stock is available within the network and following express direction from the Health | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2026:7
- Recorded
- 06 Aug 2026 21:25 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 06 Aug 2026 21:25 UTC
- Content hash
3a9c616aea68a1ed17fc1e0637a8a94fbb9bf4077a52090113d2dc48768cede2sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2026-07.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.